Compare with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES UNICHEM LAB ALKEM LABORATORIES/
UNICHEM LAB
 
P/E (TTM) x 22.4 -48.7 - View Chart
P/BV x 5.4 1.2 451.3% View Chart
Dividend Yield % 0.9 1.2 77.6%  

Financials

 ALKEM LABORATORIES   UNICHEM LAB
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
UNICHEM LAB
Mar-19
ALKEM LABORATORIES/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs2,720292 931.5%   
Low Rs1,660182 912.3%   
Sales per share (Unadj.) Rs697.9167.7 416.2%  
Earnings per share (Unadj.) Rs96.1-3.6 -2,647.4%  
Cash flow per share (Unadj.) Rs117.35.9 1,973.5%  
Dividends per share (Unadj.) Rs25.004.00 625.0%  
Dividend yield (eoy) %1.11.7 67.6%  
Book value per share (Unadj.) Rs515.2372.3 138.4%  
Shares outstanding (eoy) m119.5770.38 169.9%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.11.4 222.0%   
Avg P/E ratio x22.8-65.3 -34.9%  
P/CF ratio (eoy) x18.739.9 46.8%  
Price / Book Value ratio x4.30.6 667.7%  
Dividend payout %26.0-110.2 -23.6%   
Avg Mkt Cap Rs m261,87916,680 1,570.0%   
No. of employees `00014.32.6 550.8%   
Total wages/salary Rs m15,0552,393 629.1%   
Avg. sales/employee Rs Th5,822.64,535.2 128.4%   
Avg. wages/employee Rs Th1,050.5919.8 114.2%   
Avg. net profit/employee Rs Th802.0-98.2 -816.6%   
INCOME DATA
Net Sales Rs m83,44411,801 707.1%  
Other income Rs m1,042984 105.9%   
Total revenues Rs m84,48612,785 660.8%   
Gross profit Rs m14,734-835 -1,764.8%  
Depreciation Rs m2,528674 375.2%   
Interest Rs m65175 865.2%   
Profit before tax Rs m12,598-600 -2,100.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105-343 -321.7%   
Profit after tax Rs m11,493-256 -4,497.7%  
Gross profit margin %17.7-7.1 -249.6%  
Effective tax rate %8.857.3 15.3%   
Net profit margin %13.8-2.2 -636.1%  
BALANCE SHEET DATA
Current assets Rs m54,96020,384 269.6%   
Current liabilities Rs m32,4335,029 644.9%   
Net working cap to sales %27.0130.1 20.7%  
Current ratio x1.74.1 41.8%  
Inventory Days Days80105 76.0%  
Debtors Days Days72135 53.5%  
Net fixed assets Rs m32,7109,023 362.5%   
Share capital Rs m239141 169.8%   
"Free" reserves Rs m61,36826,058 235.5%   
Net worth Rs m61,60726,199 235.1%   
Long term debt Rs m1,5920-   
Total assets Rs m99,43331,496 315.7%  
Interest coverage x20.4-7.0 -292.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.4 224.0%   
Return on assets %12.2-0.6 -2,133.1%  
Return on equity %18.7-1.0 -1,912.7%  
Return on capital %21.0-2.0 -1,048.5%  
Exports to sales %19.169.4 27.5%   
Imports to sales %3.00-   
Exports (fob) Rs m15,9178,188 194.4%   
Imports (cif) Rs m2,483NA-   
Fx inflow Rs m16,0618,188 196.2%   
Fx outflow Rs m2,483596 416.6%   
Net fx Rs m13,5787,592 178.9%   
CASH FLOW
From Operations Rs m5,851-3,278 -178.5%  
From Investments Rs m-7,414-2,860 259.2%  
From Financial Activity Rs m792-24 -3,270.7%  
Net Cashflow Rs m-731-4,690 15.6%  

Share Holding

Indian Promoters % 66.9 50.1 133.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 15.1 219.2%  
FIIs % 0.0 3.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 31.7 -  
Shareholders   68,381 20,176 338.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  SHASUN PHARMA  

Compare ALKEM LABORATORIES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

A Time Correction in the Nifty(Momentum Moves)

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Mar 5, 2021 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - DIVIS LABORATORIES COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS